Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
about
Protein interactions in human genetic diseases.Domain atrophy creates rare cases of functional partial protein domainsCorrelating protein function and stability through the analysis of single amino acid substitutions.SDM--a server for predicting effects of mutations on protein stability and malfunction.Correlating disease-related mutations to their effect on protein stability: a large-scale analysis of the human proteome.A structural systems biology approach for quantifying the systemic consequences of missense mutations in proteins.Molecular Determinants of Mutant Phenotypes, Inferred from Saturation Mutagenesis DataNaturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains.SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease.Modulating protein stability - directed evolution strategies for improved protein function.Pathomechanistic characterization of two exonic L1CAM variants located in trans in an obligate carrier of X-linked hydrocephalus.Non-native interactions are critical for mechanical strength in PKD domains.Understanding pathogenic single-nucleotide polymorphisms in multidomain proteins--studies of isolated domains are not enough.Linking genotype and phenotype of Saccharomyces cerevisiae strains reveals metabolic engineering targets and leads to triterpene hyper-producers.A structural bioinformatics approach to the analysis of nonsynonymous single nucleotide polymorphisms (nsSNPs) and their relation to disease.Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms.
P2860
Q30367185-929D244D-879B-4ECB-AA19-65A6AA00BFB2Q30374251-1088897A-24A5-4A2D-A858-F702C8583601Q30380764-E06BA3CF-C17C-4BF1-B712-D2B248634FD8Q30402863-913565C0-0507-45B5-BF41-57706F68ABB8Q30406158-F0556327-ECD9-4090-9583-4FE46AA5C079Q30422738-629E27F6-76AC-4A68-A7BD-871900CEF11EQ31123704-0A3125F5-740F-4367-9BD2-84D773967D62Q37432198-9A37F677-DF7E-4B03-95D5-9E3C5FB35241Q37479003-C7238F22-0043-4BA7-B4CE-0F7BB0F9048AQ38109676-506F892C-0F6D-4CC9-A8F9-421AC18698F0Q39416813-316DE6B2-3E73-4F37-BEE4-FD8DCBBC3539Q40286976-2F7DB80C-44DB-4EA0-A38F-BA240592F853Q41844622-349C36A5-462F-4EF7-8DF0-B94E4C5D5A30Q42700824-E792DCFC-4B13-4285-AB66-2495FB849A87Q51897379-B60B7439-EE4F-4211-89AA-3D799ACE07C8Q54981073-55E4A2C3-7F44-450E-B7F9-020DFD9467AC
P2860
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@en
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@nl
type
label
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@en
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@nl
prefLabel
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@en
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@nl
P2093
P2860
P356
P1476
Using model proteins to quantify the effects of pathogenic mutations in Ig-like proteins.
@en
P2093
Benjamin Moore
Jane Clarke
Lucy G Randles
Stefan J Hamill
Susan B Fowler
P2860
P304
24216-24226
P356
10.1074/JBC.M603593200
P407
P577
2006-06-07T00:00:00Z